PRODUCTS SOLD ON PEPTIDESLABUAE.COM ARE FOR RESEARCH PURPOSES ONLY AND ARE NOT FOR HUMAN OR VETERINARY USE.
PRODUCTS SOLD ON PEPTIDESLABUAE.COM ARE FOR RESEARCH PURPOSES ONLY AND ARE NOT FOR HUMAN OR VETERINARY USE.
£220.00
Buy Cagrilintide + Semaglutide Peptides in UAE – In Stock & Ready to Ship
Cagrilintide and Semaglutide is a widely researched peptide combination known for its role in metabolic regulation and appetite control studies. Each batch is independently verified at ≥99% purity and comes with a full Certificate of Analysis (COA) and HPLC testing documentation — giving UAE research teams the confidence they need when sourcing peptides for serious work.
For research use only. Not intended for human or veterinary use.
Cagrilintide and Semaglutide is a dual-peptide combination being actively studied in metabolic research for its complementary roles in energy regulation, appetite signalling, and glucose homeostasis — representing one of the most talked-about peptide pairings in current obesity and metabolic science. Researchers and institutions across the UAE, Dubai, Abu Dhabi and the wider GCC can source verified, research-grade Cagrilintide + Semaglutide with fast international dispatch and full batch documentation included.
✅ ≥99% Purity — HPLC Verified
✅ Batch-Specific Certificate of Analysis (CoA) Included
✅ Lyophilised Powder | GMP Manufactured
✅ Fast International Dispatch to UAE & GCC
Cagrilintide is a long-acting amylin analogue — a synthetic version of amylin, a peptide hormone naturally co-secreted with insulin from pancreatic beta cells. In research settings, it is studied for its role in satiety signalling, gastric emptying regulation, and energy balance. Its extended half-life compared to native amylin makes it a useful tool for sustained metabolic studies in pre-clinical models.
Semaglutide is a GLP-1 receptor agonist (glucagon-like peptide-1) that has become one of the most studied compounds in metabolic and obesity research over the past decade. It mimics the action of the naturally occurring GLP-1 hormone, which plays a central role in insulin secretion, appetite regulation, and glucose control. In research environments, Semaglutide is used extensively in studies examining metabolic syndrome, pancreatic function, and energy homeostasis.
The research interest in combining these two peptides lies in their complementary — and potentially synergistic — mechanisms of action. Where Semaglutide targets GLP-1 receptors to influence glucose metabolism and appetite, Cagrilintide acts through amylin receptors to regulate satiety and gastric function via a separate but related pathway. Together, they are studied for:
Dual Receptor Pathway Research: Investigations into how simultaneous GLP-1 and amylin receptor engagement influences metabolic outcomes compared to either compound alone.
Energy Balance Studies: Research examining total caloric regulation, adipose tissue behaviour, and body composition changes in pre-clinical models.
Glucose Metabolism: Studies looking at insulin sensitivity, postprandial glucose response, and pancreatic function under combined peptide protocols.
Obesity & Metabolic Syndrome Models: The combination has attracted significant attention in pre-clinical obesity research, with studies examining its effects on weight-related metabolic markers across multiple animal models.
Appetite and Satiety Signalling: Research into central nervous system pathways governing food intake behaviour and hunger regulation.
This combination — sometimes referred to in research literature under the investigational name CagriSema — has become one of the most closely watched dual-peptide protocols in metabolic science:
Pre-clinical studies have reported notably greater reductions in body weight markers when both compounds are used together compared to either alone, suggesting additive or synergistic effects through their distinct receptor pathways. Phase research programmes examining this combination have explored its behaviour across a range of metabolic endpoints including HbA1c-equivalent markers, body mass, and lipid profiles in animal models. The complementary nature of amylin and GLP-1 signalling — both involved in post-meal metabolic regulation but through different mechanisms — has made this pairing a logical focus for researchers studying multi-pathway metabolic intervention. Semaglutide individually has one of the largest pre-clinical and clinical research footprints of any GLP-1 compound, providing a strong foundation of comparative data for combination studies.
| Parameter | Specification |
|---|---|
| Components | Cagrilintide (Amylin Analogue) + Semaglutide (GLP-1 Agonist) |
| Purity | ≥99% Each (HPLC Verified) |
| Form | White Lyophilised Powder |
| Solubility | Bacteriostatic water, sterile water |
| Storage (powder) | -20°C, protect from light |
| Storage (reconstituted) | 2–8°C, use within 2–4 weeks |
Every order dispatched to the UAE and GCC includes:
Can I buy Cagrilintide + Semaglutide in the UAE?
Yes. We supply research-grade Cagrilintide and Semaglutide with international dispatch to the UAE, Dubai, Abu Dhabi, Sharjah and across the GCC. All orders include full batch documentation and are packaged to maintain peptide integrity throughout transit.
What is CagriSema?
CagriSema is the investigational name used in some research literature to describe the combination of Cagrilintide and Semaglutide when studied together as a dual-peptide protocol. It refers to the same pairing available here for pre-clinical research purposes.
Why combine Cagrilintide and Semaglutide in research?
The two peptides act on different but related receptor systems — GLP-1 receptors (Semaglutide) and amylin receptors (Cagrilintide) — both of which are involved in metabolic and appetite regulation. Research into their combined use explores whether engaging both pathways simultaneously produces different or enhanced outcomes compared to single-peptide protocols.
How is this combination reconstituted for research?
Each compound should be reconstituted separately unless your protocol specifies otherwise. Allow each vial to reach room temperature, add sterile or bacteriostatic water slowly down the vial wall, and swirl gently without shaking. Aliquot and store at -80°C if long-term storage is required.
What purity standard is used?
Both Cagrilintide and Semaglutide are independently verified to ≥99% purity via HPLC, with full certificates of analysis provided for each compound per batch.
How quickly is this delivered to UAE?
Orders are dispatched promptly via tracked international courier. Delivery to the UAE typically takes 3–5 working days, with temperature-considerate packaging used throughout.
Research Disclaimer: Cagrilintide and Semaglutide are supplied exclusively for legitimate scientific research purposes conducted within licensed laboratory environments. These products are not intended for human consumption, self-administration, or any therapeutic application. They must be handled by qualified researchers in compliance with applicable UAE regulations and institutional ethics guidelines. Handling should only be performed by qualified laboratory professionals in controlled research settings. By purchasing, you confirm that these compounds will be used solely for approved in-vitro or pre-clinical research purposes.
Receive News
